Beyond triple-negative breast cancer: the need to define new subtypes (Q37782088)

23 August 2017

title

Beyond triple-negative breast cancer: the need to define new subtypes (English)

1 reference

triple-negative breast cancer

23 August 2017

main subject

1 reference

3

Jorge S Reis-Filho

1 reference

23 August 2017

Anastasia Constantinidou

1

object named as

Anastasia Constantinidou

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735307

22 June 2024

2

Robin L. Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735307

22 June 2024

author name string

Jorge S. Reis-Filho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735307

22 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20735307

22 June 2024

publication date

1 August 2010

1 reference

full work available at URL

23 August 2017

http://www.future-drugs.com/doi/abs/10.1586/era.10.50

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20735307

http://www.tandfonline.com/doi/pdf/10.1586/era.10.50

22 June 2024

1 reference

Expert Review of Anticancer Therapy

22 June 2024

published in

1 reference

23 August 2017

volume

10

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

1197-1213

1 reference

Prognostic markers in triple-negative breast cancer

23 August 2017

cites work

1 reference

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

21 January 2018

1 reference

Triple negative tumours: a critical review

21 January 2018

1 reference

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant chemotherapy: results of WSG AM-01 trial

21 January 2018

1 reference

Molecular portraits of human breast tumours

21 January 2018

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

Breast cancer molecular profiling with single sample predictors: a retrospective analysis

21 January 2018

1 reference

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

Molecular classification of breast cancer: limitations and potential

21 January 2018

1 reference

Gene-expression signatures in breast cancer

21 January 2018

1 reference

The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.

21 January 2018

1 reference

Histological and molecular types of breast cancer: is there a unifying taxonomy?

21 January 2018

1 reference

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

21 January 2018

1 reference

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

Basal-like breast cancer: a critical review

21 January 2018

1 reference

How basal are triple-negative breast cancers?

21 January 2018

1 reference

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

21 January 2018

1 reference

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

21 January 2018

1 reference

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

Are triple-negative tumours and basal-like breast cancer synonymous?

21 January 2018

1 reference

Refinement of breast cancer classification by molecular characterization of histological special types

21 January 2018

1 reference

Molecular subtypes in breast cancer evaluation and management: divide and conquer

21 January 2018

1 reference

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer

21 January 2018

1 reference

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer

21 January 2018

1 reference

An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer

21 January 2018

1 reference

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

21 January 2018

1 reference

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

21 January 2018

1 reference

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

21 January 2018

1 reference

Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer

21 January 2018

1 reference

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

21 January 2018

1 reference

Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status

21 January 2018

1 reference

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures

21 January 2018

1 reference

Subtypes of breast cancer show preferential site of relapse

21 January 2018

1 reference

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases

21 January 2018

1 reference

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

21 January 2018

1 reference

Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

21 January 2018

1 reference

An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

21 January 2018

1 reference

Complex landscapes of somatic rearrangement in human breast cancer genomes

21 January 2018

1 reference

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

BRCA1 dysfunction in sporadic basal-like breast cancer

21 January 2018

1 reference

Basal-like breast cancer and the BRCA1 phenotype

21 January 2018

1 reference

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

21 January 2018

1 reference

Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum

21 January 2018

1 reference

Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).

21 January 2018

1 reference

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

21 January 2018

1 reference

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

21 January 2018

1 reference

Metaplastic breast carcinomas are basal-like tumours

21 January 2018

1 reference

Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis

21 January 2018

1 reference

Biphasic metaplastic sarcomatoid carcinoma of the breast

21 January 2018

1 reference

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

21 January 2018

1 reference

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

21 January 2018

1 reference

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis

21 January 2018

1 reference

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

21 January 2018

1 reference

Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes

21 January 2018

1 reference

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue

21 January 2018

1 reference

AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer

21 January 2018

1 reference

Nestin is expressed in basal-like and triple negative breast cancers.

21 January 2018

1 reference

CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification

21 January 2018

1 reference

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

High frequency of TP53 mutation in BRCA1 and sporadic basal-like carcinomas but not in BRCA1 luminal breast tumors

21 January 2018

1 reference

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

21 January 2018

1 reference

Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancers

21 January 2018

1 reference

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

21 January 2018

1 reference

Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer

21 January 2018

1 reference

Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data

21 January 2018

1 reference

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.

21 January 2018

1 reference

Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer

21 January 2018

1 reference

A mouse model of basal-like breast carcinoma with metaplastic elements

21 January 2018

1 reference

DNA copy number alterations and expression of relevant genes in triple-negative breast cancer

21 January 2018

1 reference

Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets

21 January 2018

1 reference

Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array.

21 January 2018

1 reference

Tiling path genomic profiling of grade 3 invasive ductal breast cancers

21 January 2018

1 reference

BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles

21 January 2018

1 reference

Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions

21 January 2018

1 reference

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

21 January 2018

1 reference

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma

21 January 2018

1 reference

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

21 January 2018

1 reference

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.

21 January 2018

1 reference

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative" breast cancer cell lines growing in vitro

21 January 2018

1 reference

Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: rationale for patient selection

21 January 2018

1 reference

Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition

21 January 2018

1 reference

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells

21 January 2018

1 reference

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

21 January 2018

1 reference

AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer

21 January 2018

1 reference

Integrated functional, gene expression and genomic analysis for the identification of cancer targets

21 January 2018

1 reference

Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs

21 January 2018

1 reference

Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models

21 January 2018

1 reference

TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype

21 January 2018

1 reference

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

21 January 2018

1 reference

Patterns of somatic mutation in human cancer genomes

21 January 2018

1 reference

A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer.

21 January 2018

1 reference

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

21 January 2018

1 reference

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

21 January 2018

36

1 reference

KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome

22 June 2024

51

1 reference

Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication

22 June 2024

53

1 reference

DIFFERENTIATION PATHWAYS IN PRIMARY INVASIVE BREAST CARCINOMA AS SUGGESTED BY INTERMEDIATE FILAMENT AND BIOPATHOLOGICAL MARKER EXPRESSION

22 June 2024

60

1 reference

Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis.

22 June 2024

72

1 reference

Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization

22 June 2024

87

1 reference

Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH

22 June 2024

89

1 reference

Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients

22 June 2024

95

1 reference

Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition

22 June 2024

98

1 reference

RiBBON 1 and RiBBON 2: phase III trials of bevacizumab with standard chemotherapy for metastatic breast cancer

22 June 2024

104

1 reference

22 June 2024

105

69

495S

Brufsky

2009

1 reference

Does massively parallel DNA resequencing signify the end of histopathology as we know it?

22 June 2024

123

1 reference

22 June 2024

Identifiers

DOI

10.1586/ERA.10.50

1 reference

23 August 2017

1 reference